0001786195-25-000001.txt : 20250829 0001786195-25-000001.hdr.sgml : 20250829 20250829102649 ACCESSION NUMBER: 0001786195-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250829 DATE AS OF CHANGE: 20250829 EFFECTIVENESS DATE: 20250829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Swing Therapeutics, Inc. CENTRAL INDEX KEY: 0001786195 ORGANIZATION NAME: EIN: 842110970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-556228 FILM NUMBER: 251277256 BUSINESS ADDRESS: STREET 1: 548 MARKET STREET, #63989 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 548 MARKET STREET, #63989 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D 1 primary_doc.xml X0708 D LIVE 0001786195 Swing Therapeutics, Inc. 548 MARKET STREET, #63989 SAN FRANCISCO CA CALIFORNIA 94104 000-000-0000 DELAWARE None None Corporation true Michael Rosenbluth 548 MARKET STREET, #63989 San Francisco CA CALIFORNIA 94104 Executive Officer Director Andrew Firlik 548 MARKET STREET, #63989 San Francisco CA CALIFORNIA 94104 Director Zack Lynch 548 MARKET STREET, #63989 San Francisco CA CALIFORNIA 94104 Director Corey McCann 548 MARKET STREET, #63989 San Francisco CA CALIFORNIA 94104 Director Other Health Care Decline to Disclose 06b false 2025-05-28 true true true false 0 14550161 11377712 3172449 false 14 0 0 0 false Swing Therapeutics, Inc. /s/ Michael Rosenbluth Michael Rosenbluth Chief Executive Officer 2025-08-29